Novartis AG's Fiscal Year is From January To December - All Figures are in Percent.
The item "Net-Profit-Margin" stands at 25.53 percent as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Net Profit Margin" stands at 25.53 Percent. This represents an increase of 6.57 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -9.72 percentage points compared to the value the year prior.
The 1 year change in percentage points is -9.72.
The 3 year change in percentage points is -17.88.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Profit Margin | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Profit Margin | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Profit Margin | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Profit Margin | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Profit Margin | 280,205,508,085.11 |